Breaking News
December 16, 2018 - Parents spend more time talking with kids about mechanics of using mobile devices
December 16, 2018 - Biohaven Announces Positive Results from Ongoing Rimegepant Long-Term Safety Study
December 16, 2018 - Arterial stiffness may predict dementia risk
December 16, 2018 - Study explores link between work stress and increased cancer risk
December 16, 2018 - Sex work criminalization linked to incidences of violence finds study
December 16, 2018 - Johns Hopkins researchers discover swarming behavior in fish-dwelling parasite
December 16, 2018 - Schistosomiasis prevention and treatment could help control HIV
December 16, 2018 - Early postpartum opioids linked with persistent usage
December 16, 2018 - Johns Hopkins researchers identify molecular causes of necrotizing enterocolitis in preemies
December 16, 2018 - Advanced illumination expands capabilities of light-sheet microscopy
December 16, 2018 - Alzheimer’s could possibly be spread via contaminated neurosurgery
December 16, 2018 - Unraveling the complexity of cancer biology can prompt new avenues for drug development
December 16, 2018 - Inflammatory Bowel Disease, Prostate Cancer Linked
December 16, 2018 - Cannabis youth prevention strategy should target mental wellbeing
December 15, 2018 - Recent developments and challenges in hMAT inhibitors
December 15, 2018 - Sewage bacteria found lurking in Hudson River sediments
December 15, 2018 - CDC selects UMass Amherst biostatistician model that helps predict influenza outbreaks
December 15, 2018 - Researchers reveal brain mechanism that drives itch-evoked scratching behavior
December 15, 2018 - New computer model helps predict course of the disease in prostate cancer patients
December 15, 2018 - Obesity to Blame for Almost 1 in 25 Cancers Worldwide
December 15, 2018 - How the brain tells you to scratch that itch
December 15, 2018 - New findings could help develop new immunotherapies against cancer
December 15, 2018 - World’s largest AI-powered medical research network launched by OWKIN
December 15, 2018 - Young people suffering chronic pain battle isolation and stigma as they struggle to forge their identities
December 15, 2018 - Lifespan extension at low temperatures depends on individual’s genes, study shows
December 15, 2018 - New ingestible capsule can be controlled using Bluetooth wireless technology
December 15, 2018 - Researchers uncover microRNAs involved in the control of social behavior
December 15, 2018 - Research offers hope for patients with serious bone marrow cancer
December 15, 2018 - Link between poverty and obesity is only about 30 years old, study shows
December 15, 2018 - Mass spectrometry throws light on old case of intentional heavy metal poisoning
December 15, 2018 - BeyondSpring Announces Phase 3 Study 105 of its Lead Asset Plinabulin for Chemotherapy-Induced Neutropenia Meets Primary Endpoint at Interim Analysis
December 15, 2018 - Study finds that in treating obesity, one size does not fit all
December 15, 2018 - Tenacity and flexibility help maintain psychological well-being, mobility in older people
December 15, 2018 - Study reveals role of brain mechanism in memory recall
December 15, 2018 - High levels of oxygen encourage the brain to remain in deep, restorative sleep
December 15, 2018 - Experimental HIV vaccine strategy works in non-human primates, research shows
December 15, 2018 - Genetically modified pigs could limit replication of classical swine fever virus, study shows
December 15, 2018 - FDA Approves Herzuma (trastuzumab-pkrb), a Biosimilar to Herceptin
December 15, 2018 - Cost and weight-loss potential matter most to bariatric surgery patients
December 15, 2018 - Cancer Research UK and AstraZeneca open new Functional Genomics Centre
December 15, 2018 - New research lays out potential path for treatment of Huntington’s disease
December 15, 2018 - Prestigious R&D 100 Award presented to Leica Microsystems
December 15, 2018 - Study shows septin proteins detect and kill gut pathogen, Shigella
December 15, 2018 - Study sheds new light on disease-spreading mosquitoes
December 15, 2018 - 2017 Saw Slowing in National Health Care Spending
December 15, 2018 - Monitoring movement reflects efficacy of mandibular splint
December 15, 2018 - Study supports BMI as useful tool for assessing obesity and health
December 15, 2018 - Self-guided, internet-based therapy platforms effectively reduce depression
December 15, 2018 - Organically farmed food has bigger climate impact than conventional food production
December 15, 2018 - Faster, cheaper test has potential to enhance prostate cancer evaluation
December 15, 2018 - Researchers study abnormal blood glucose levels of patients after hospital discharge
December 15, 2018 - Swedish scientists explore direct association of dementia and ischemic stroke deaths
December 15, 2018 - Study finds 117% increase in number of dementia sufferers in 26 years
December 15, 2018 - Eczema Can Drive People to Thoughts of Suicide: Study
December 15, 2018 - Link between neonatal vitamin D deficiency and schizophrenia confirmed
December 15, 2018 - Nurse denied life insurance because she carries naloxone
December 15, 2018 - Ritalin drug affects organization of pathways that build brain networks used in attention, learning
December 15, 2018 - Research pinpoints two proteins involved in creation of stem cells
December 15, 2018 - Gut bacteria may modify effectiveness of anti-diabetes drugs
December 15, 2018 - A new type of ‘painless’ adhesive for biomedical applications
December 15, 2018 - Early physical therapy associated with reduction in opioid use
December 15, 2018 - Breast cancer protection from pregnancy begins many decades later, study finds
December 15, 2018 - How often pregnant women follow food avoidance strategy to prevent allergy in offspring?
December 15, 2018 - Using machine learning to predict risk of developing life-threatening infections
December 15, 2018 - How imaginary friends could boost children’s development
December 15, 2018 - Folate deficiency creates more damaging chromosomal abnormalities than previously known
December 15, 2018 - Study provides new insights into molecular mechanisms underlying role of amyloid in Alzheimer’s disease
December 15, 2018 - For the asking, a check is in the mail to help pay for costly drugs
December 15, 2018 - UA scientists uncover biological processes leading to rare brain disorder in babies
December 15, 2018 - The largest database on industrial poisons
December 15, 2018 - ESMO Immuno-Oncology Congress showcases novel technologies set to benefit many cancer patients
December 15, 2018 - Ovid Therapeutics Announces Plans to Move into a Phase 3 Trial in Pediatric Patients Based on End-of-Phase 2 Meeting for OV101 in Angelman Syndrome
December 15, 2018 - Left ventricular noncompaction – Genetics Home Reference
December 15, 2018 - Children’s sleep not significantly affected by screen time, new study finds
December 15, 2018 - When should dementia patients stop driving? A new guidance for clinicians
December 15, 2018 - Researchers use INTEGRA’s VIAFLO 96/384 to streamline the experimental workflow
December 15, 2018 - Researchers discover protein involved in nematode stress response
December 15, 2018 - Cancer patients have greater risk of developing shingles, study shows
December 14, 2018 - UAlberta scientists identify biomarkers for detecting Alzheimer’s disease in saliva samples
December 14, 2018 - Study uncovers link between tube travel and spread of flu-like illnesses
New discovery restores insulin cell function in type 2 diabetes

New discovery restores insulin cell function in type 2 diabetes

image_pdfDownload PDFimage_print
Credit: CC0 Public Domain

By blocking a protein, VDAC1, in the insulin-producing beta cells, it is possible to restore their normal function in case of type 2 diabetes. In preclinical experiments, the researchers behind a new study have also shown that it is possible to prevent the development of the disease. The findings are published in the scientific journal Cell Metabolism.

The researchers at Lund University in Sweden believe that the active substance, which inhibits the protein VDAC1, could play a part in future drug development for the treatment of type 2 diabetes.

“The goal is to be able to administer the substance to newly diagnosed type 2 diabetics to allow the insulin-producing beta cells to retain their function. Or, even better, to give it to pre-diabetics to prevent the onset of type 2 diabetes”, says Associate Professor and research team leader Albert Salehi, who conducted the study together with Professor Claes Wollheim.

“It is a small study based on cell donations from six deceased people with type 2 diabetes, as well as a limited number of experiments in animal models. Further studies are needed to demonstrate how blocking VDAC1 affects kidney, heart, muscle and fat tissue, for example. However, the results thus far have been so promising that we have patented the use of the active substance within the diabetes field. We are very happy about that, and this initial study would not have been possible without the financial support from the Forget Foundation”, says Albert Salehi.

On the cell surface instead of inside the cell

Pre-diabetics may experience elevated blood glucose levels for many years before developing type 2 diabetes. High glucose levels initiate a series of negative processes. Among other things, they increase the production of VDAC1, a so-called channel protein within the cells that, with the help of a substance, ATP, releases energy from the cell’s power plants, the mitochondria, to other parts of the cell, to be used for insulin secretion.

At constant high levels of glucose, however, the levels of the VDAC1 protein increase, causing VDAC1 to attach also to the cell surface. The energy (ATP) then leaks out of the cell and causes cell death due to a lack of energy. This, in turn, leads to impaired blood glucose control that eventually causes organ complications, such as cardiovascular disease, kidney disease, blindness and stroke.

Normalised insulin secretion

When the researchers blocked VDAC1 in beta cells from organ donors with type 2 diabetes, the energy supply was restored and the insulin secretion was normalised.

The experiments were subsequently repeated on mice, which are known to develop genetically conditioned diabetes. As a result, the disease did not develop and the insulin production was maintained for five weeks, at which point the treatment was discontinued and the glucose levels increased.

“It is a small study performed on cells from six deceased donors with type 2 diabetes as well as a limited number of experiments on animal models. Further studies are needed to demonstrate how blocking of VDAC1 affects tissues such as kidneys, heart muscles and fat. But pursuing the findings and performing the studies on humans requires more funding”, says Albert Salehi.

New discoveries about metformin

In addition to specific VDAC1 antibodies and VDAC1 inhibitors obtained in collaboration with Israeli researchers, the researchers in Lund also used the diabetes drug, metformin, and achieved the same effect.

“We have shown a whole new mechanism for how metformin works on beta cells. The fact that metformin not only works outside the pancreas but also protects the beta cells and improves insulin secretion in people with type 2 diabetes was recently demonstrated by a Canadian research team. The effect is probably achieved through an impact on VDAC1”, says Albert Salehi.

Connection to Alzheimer’s disease

There are connections between type 2 diabetes, dementia and Alzheimer’s disease. The authors of the study point out that there is also a link between VDAC1 and Alzheimer’s disease, as high levels of VDAC1 can be found in brain cells in the parts of the brain that are affected at an early stage of the disease.

“We believe that the substance may have a good effect also on these patients by preventing the brain cells from dying and thereby improving the patients’ cognitive abilities”, says Albert Salehi.

Facts: Type 2 diabetes

Diabetes is one of the major widespread diseases, affecting more than 400 million people worldwide. Approximately 200 million people have diabetes without knowing it. The disease is caused by genetics and lifestyle. An improved diet and more exercise can be sufficient treatment for some, while others need drugs. Like other forms of diabetes, type 2 diabetes can lead to cardiovascular disease, damage to the eyes, kidneys and nerves.

Facts: VDAC1 and VDAC2

In most studied tissues and cells, VDAC1 is more prevalent than VDAC2. Both VDAC1 and VDAC2 function as ion channels that allow ATP to penetrate.

In beta cells, however, VDAC2 is more prevalent, which indicates that it plays an important role in the beta cells. However, islets (with beta cells) donated from deceased persons with type 2 diabetes have more VDAC1 and less VDAC2, compared to islets from healthy donors.

The proteins act as each other’s opposites: when VDAC1 increases, VDAC2 decreases and vice versa. This discovery was also made by our research team.

Using confocal microscopes, the researchers were able to locate VDAC1 but not VDAC2 to the surface of the beta cells in type 2 diabetics. In healthy cells and the cells from people who were treated with metformin, the protein was rather located inside the cells on the mitochondria. This was confirmed by immunofluorescence staining of the pancreas of non-diabetics and type 2 diabetics.


Explore further:
New potential target for treatment of diabetes

More information:
Enming Zhang et al. Preserving Insulin Secretion in Diabetes by Inhibiting VDAC1 Overexpression and Surface Translocation in β Cells, Cell Metabolism (2018). DOI: 10.1016/j.cmet.2018.09.008

Journal reference:
Cell Metabolism

Provided by:
Lund University

Tagged with:

About author

Related Articles